Probe of Alibaba unearthed evidence it knowingly let dangerous drugs be sold to U.S. consumers — but DOJ did not prosecute
For eight years, Chinese online retailer Alibaba and its U.S. payment processing company failed to prevent dangerous drugs, chemicals and pill presses from being sold to American customers — even after employees warned of compliance problems, public records show. Prosecutors at the Justice Department believed they had enough evidence to prove that the companies had … Read more